Lumbar Interbody Fusion and Osteobiologics for Lumbar Fusion
- Author:
Young-Hoon KIM
1
;
Kee-Yong HA
;
Youn-Soo KIM
;
Ki-Won KIM
;
Kee-Won RHYU
;
Jong-Beom PARK
;
Jae-Hyuk SHIN
;
Young-Yul KIM
;
Jun-Seok LEE
;
Hyung-Youl PARK
;
Jaeryong KO
;
Sang-Il KIM
Author Information
- Publication Type:Review Article
- From:Asian Spine Journal 2022;16(6):1022-1033
- CountryRepublic of Korea
- Language:English
- Abstract: Lumbar interbody fusion (LIF) is an excellent treatment option for a number of lumbar diseases. LIF can be performed through posterior, transforaminal, anterior, and lateral or oblique approaches. Each technique has its own pearls and pitfalls. Through LIF, segmental stabilization, neural decompression, and deformity correction can be achieved. Minimally invasive surgery has recently gained popularity and each LIF procedure can be performed using minimally invasive techniques to reduce surgery-related complications and improve early postoperative recovery. Despite advances in surgical technology, surgery-related complications after LIF, such as pseudoarthrosis, have not yet been overcome. Although autogenous iliac crest bone graft is the gold standard for spinal fusion, other bone substitutes are available to enhance fusion rate and reduce complications associated with bone harvest. This article reviews the surgical procedures and characteristics of each LIF and the osteobiologics utilized in LIF based on the available evidence.
